Phase 3 TRIUMPH-1 Trial Results (2026 Update) TRIUMPH-1 is the pivotal Phase 3 obesity trial for retatrutide
Introduction to GLP-1 Agonists GLP-1 agonists have been pivotal in the pharmaceutical market for nearly two decades, beginning with the FDA approval of AstraZenecas Byetta in 2005
Certain red flags require prompt medical evaluation
5.4.2 Effects on liver Despite the lack of expression of GIPR (41, 191) and GLP-1R (192, 193) in hepatocytes, both GIP and GLP-1 have indirect effects on hepatic lipid and glucose metabolism (194)
233 , 116.e1116.e7 (2025)
CMS currently lists eligible drugs for weight reduction and weight maintenance under the Medicare GLP-1 Bridge as: Foundayo Wegovy , including injection and tablets Zepbound , limited to the KwikPen formulation The list may change during the program